NuCana is a clinical stage biopharmaceutical company developing and commercialising novel anti-cancer medicines.

With its next generation of anti-cancer agents (nucleotide analogues), NuCana is setting new benchmarks for innovative therapeutic treatments. The state-of-the-art ProTide technology transforms existing therapies into better and safer medicines that overcome key cancer resistance mechanisms.

Company Growth (employees)
Edinburgh, GB
Size (employees)
19 (est)+12%
NuCana was founded in 2008 and is headquartered in Edinburgh, GB

Key People at NuCana

Hugh S. Griffith

Hugh S. Griffith

Co-Founder, CEO & Board Member
Ian Abercrombie

Ian Abercrombie

Business Unit Director
Chris Wood

Chris Wood

Executive Chairman & Medical Director

NuCana Office Locations

NuCana has an office in Edinburgh
Edinburgh, GB (HQ)
10 Lochside Place

NuCana Metrics

Summary Metrics

Founding Date


Total Funding

$67.5 m

Latest funding size

$57 m

Time since last funding

about 3 years


NuCana's latest funding round in April 2014 was reported to be $57 m. In total, NuCana has raised $67.5 m

NuCana Online Presence

NuCana Company Life

You may also be interested in